| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 15.435 | 68.199 | 63.918 | 90.041 | 88.885 | 97.206 | 91.215 | 75.573 |
| Total Income - EUR | - | - | 15.435 | 68.199 | 63.919 | 90.042 | 88.886 | 97.207 | 91.216 | 75.574 |
| Total Expenses - EUR | - | - | 8.656 | 37.924 | 32.190 | 30.736 | 37.425 | 41.145 | 36.300 | 42.555 |
| Gross Profit/Loss - EUR | - | - | 6.779 | 30.275 | 31.729 | 59.306 | 51.461 | 56.062 | 54.915 | 33.020 |
| Net Profit/Loss - EUR | - | - | 6.625 | 29.595 | 31.090 | 58.463 | 50.724 | 55.154 | 54.122 | 30.979 |
| Employees | - | - | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Comendomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 0 | 0 | 0 | 18.141 | 12.998 | 8.414 | 3.047 |
| Current Assets | - | - | 11.386 | 35.311 | 36.708 | 60.657 | 35.724 | 76.862 | 64.254 | 30.671 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
| Receivables | - | - | 8.845 | 8.897 | 13.257 | 16.185 | 12.121 | 40.884 | 45.016 | 21.266 |
| Cash | - | - | 2.541 | 26.414 | 23.451 | 44.472 | 23.603 | 35.978 | 19.237 | 9.394 |
| Shareholders Funds | - | - | 6.669 | 29.638 | 31.132 | 58.504 | 50.765 | 55.195 | 54.170 | 31.027 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.744 | 5.673 | 5.576 | 2.153 | 3.100 | 34.665 | 18.498 | 2.690 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Comendomed Srl